AdobeStock_210711813

Self Care Forum venous disease fact sheet

2021-06-11T09:16:00+01:00By

A summary of recommendations for advising patients and the public on managing venous disease

AdobeStock_133646819

HEART UK Managing hyperlipidaemia and COVID-19

2021-02-17T14:44:00+00:00By HEART UK

A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19

doctor with elderly man

Consensus guideline on the holistic management of patients requiring anticoagulation

2020-06-03T06:57:00+01:00By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.

Pad+stethoscope 640x426

Stable peripheral arterial disease guideline

2018-12-07T15:50:00+00:00By Working party—Begg Antoniou Fay Garnham Nuttall

This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.

Pregnant women with GP AS

Stable coronary artery disease guideline

2018-12-04T12:08:00+00:00By Working party­—Fay Banerjee Begg Bostock-Cox Gordon

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of a grant from Bayer plc.

Erythrocytes tinted SIGN Red

SIGN antithrombotics guideline

2014-11-06T00:00:00+00:00By

A clear SIGN guideline summary exploring antiplatelet and anticoagulant agents and indications for their use, including cardiac and cerebrovascular disease.

Resource hub

  • Practical guide to recording ankle brachial pressure index (ABPI)

Educational resources

Index image2

Modern management of stroke prevention in non-valvular atrial fibrillation

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

These promotional videos have been funded by Bristol Myers Squibb on behalf of the BMS / Pfizer Alliance and developed in conjunction with Guidelines.  The promotional content on this page is intended for UK healthcare professionals only.
View ELIQUIS (apixaban) prescribing and adverse event reporting information
432-GB-2100689 | Date of preparation: August 2021

Webinar banner 2

The impact of DOACs on stroke in patients with NVAF: practical considerations for those with comorbidities

Commissioned by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance

This promotional webinar has been funded by Bristol Myers Squibb on behalf of the BMS – Pfizer Alliance and organised in partnership with Guidelines.
ELIQUIS (apixaban) prescribing and adverse event reporting information.
432-GB-2100774 | August 2021

Calculating renal function animation

Calculating renal function in patients with atrial fibrillation

Developed and funded by the Bristol Myers Squibb/Pfizer Alliance

This animation has been developed and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals.

432-GB-2100230  June 2021

Video index image

The holistic management of patients requiring anticoagulation

Commissioned by Bayer plc

This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines
View Xarelto(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021

doctor with elderly man

Consensus guideline on the holistic management of patients requiring anticoagulation

By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.